LIUDMILA VERDES MOREIRAS: Open Payments
NPI 1194216077 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,009 in 46 payments from 12 companies in 2025. Trend: 2023 $1,081 · 2024 $787 · 2025 $2,009
Food & beverage: $1,333Travel & lodging: $675
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 3 | $910 |
| AstraZeneca Pharmaceuticals LP | 8 | $330 |
| GlaxoSmithKline, LLC. | 15 | $202 |
| Insmed, Inc. | 7 | $174 |
| Actelion Pharmaceuticals US, Inc. | 1 | $91 |
| Grifols Shared Services North America, Inc. | 1 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Baxter Healthcare | 2 | $43 |
| Lilly USA, LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
Products named: FASENRA, Arikayce, TRELEGY ELLIPTA, Prolastin-C Liquid, OPSUMIT, AIRSUPRA, DUPIXENT, NUCALA.
Industry payments across FL — which companies pay providers there.
